-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Continuous blood glucose monitoring (CGM) is recommended for type 1 diabetic patients; CGM for insulin-treated type 2 diabetic patients lacks observational evidence
.
In diabetic patients receiving insulin therapy, is there any clinical benefit in real-time continuous blood glucose monitoring (CGM)? Andrew J.
Karte et al.
Diabetes evaluated the clinical results of real-time CGM .
The study was an exploratory retrospective cohort study of the changes in results related to the initiation of real-time CGM, using variance analysis to estimate
.
A total of 41,753 insulin-treated diabetic patients (5673 cases of type 1 DM; 36 080 cases of type 2 DM) received treatment from the Northern California Comprehensive Medical Service System (2014-2019), received insulin therapy, and self-monitored blood glucose levels.
Use CGM
.
Measure 10 endpoints 12 months before baseline and 12 months after baseline: HbA1c; hypoglycemia (for emergency or hospital use); hyperglycemia (for emergency department or hospital use); HbA1c levels below 7%, below 8%, More than 9%; 1 or more visits to the emergency department for any reason; 1 or more hospitalizations for any reason; number of outpatient visits and phone calls
.
The real-time CGM initiation group included 3806 patients (mean age 42.
4 years [SD, 19.
9 years]; 51% women; 91% type 1 and 9% type 2); the non-CGM group included 37947 patients (mean age 63.
The rate of hypoglycemia in the real-time CGM group decreased from 5.
Compared with patients who did not use DM, patients with diabetes who received insulin therapy who underwent real-time continuous blood glucose monitoring had a significant improvement in glycosylated hemoglobin, and fewer people went to emergency and hospitalization due to hypoglycemia
Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R.
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R.
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
JAMA.
2021;325(22):2273-2284 .
doi:10.
1001/jama.
2021.
6530 Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R.
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
JAMA.
Here leave a message